Novonesis (Novozymes) B
NSISBC
Pozycja w akcjach
#1146
Established in January 2024 through the amalgamation of Novozymes A/S and Chr.... Established in January 2024 through the amalgamation of Novozymes A/S and Chr. Hansen, Novonesis now stands as a prominent global leader in biosolutions. The firm's activities encompass the worldwide development and commercialization of industrial enzymes, diverse microorganisms, and vital biopharmaceutical ingredients. Distinctively, its Class B shares are listed independently and actively traded on various European exchanges.
Cena akcji
$71.97
Kapitalizacja rynkowa
$20.00B
Zmiana (1 dzień)
2.66%
Zmiana (1 rok)
13.50%
Kraj
DK
Handel Novonesis (Novozymes) B (NSISBC)
Kategoria
Basic Materials
Wskaźnik P/S dla Novonesis (Novozymes) B (NSISBC)
Wskaźnik P/S na dzień October 2026 TTM: 6.15
Według najnowszych raportów finansowych i ceny akcji Novonesis (Novozymes) B, obecny wskaźnik P/S (TTM) wynosi 6.15. Na koniec 2024 wynosił 29.56.
Historia wskaźnika P/S dla Novonesis (Novozymes) B od 2013 do 2026
Wskaźnik P/S na koniec każdego roku
| Rok | Wskaźnik P/S | Zmień |
|---|---|---|
| 2026 (TTM) | 6.15 | -84.88% |
| 2025 | 40.69 | 37.68% |
| 2024 | 29.56 | 418.90% |
| 2023 | 5.70 | 1.94% |
| 2022 | 5.59 | -44.05% |
| 2021 | 9.99 | 42.76% |
| 2020 | 6.99 | 7.66% |
| 2019 | 6.50 | 10.95% |
| 2018 | 5.86 | -19.27% |
| 2017 | 7.25 | 38.95% |
| 2016 | 5.22 | -28.57% |
| 2015 | 7.31 | 11.28% |
| 2014 | 6.57 | 6.16% |
| 2013 | 6.19 | 0.00% |
Wskaźnik P/S dla podobnych firm lub konkurentów
| Firma | Wskaźnik P/S | Różnica wskaźnika P/S | Kraj |
|---|---|---|---|
| 6.56 | 6.61% |
GB
|
|
| 4.06 | -33.96% |
FR
|
|
| 3.23 | -47.52% |
US
|
|
| 4.79 | -22.07% |
US
|
|
| 5.35 | -13.05% |
US
|
